Inhibition Of Inflammation And Senescence With Azole Compound C7 Enables Expansion Of Hematopoietic Stem And Progenitor Cells
Imagine a special type of cell in your body, called hematopoietic stem and progenitor cells (HSPCs), that are like master cells for your blood and immune system. They have the amazing ability to create all the different kinds of blood cells you need throughout your life. Sometimes, for medical treatments like bone marrow transplants, we need more of these vital cells than are readily available. Scientists have discovered a new compound, C7, that helps these master cells multiply outside the body. This is a big deal because it could mean more successful transplants and new ways to treat blood disorders. C7 works by tackling two key problems that limit the growth of these cells: inflammation and senescence. Inflammation is your body’s natural response to injury or infection, but chronic inflammation can harm healthy cells. Senescence, often called cellular aging, is when cells stop dividing and can even release harmful substances. By putting a stop to these processes, C7 allows the HSPCs to grow and thrive, maintaining their ability to renew themselves and produce all necessary blood cell types. This breakthrough could lead to better outcomes for patients needing these cells and potentially open doors for new anti-aging and regenerative therapies.
Source: link to paper